![90-year-old Jether Tiller of Maple Heights received the COVID-19 vaccine at University Hospitals on Jan.19, 2020. Cleveland's Black residents make up about half of the city鈥檚 population but during the virus鈥� first peak in July, 73 percent of hospitalized patient and 60 percent of the deaths were among Black residents. [University Hospitals]](https://npr.brightspotcdn.com/dims4/default/fd7587b/2147483647/strip/true/crop/3000x2000+0+0/resize/840x560!/format/webp/quality/90/?url=http%3A%2F%2Fnpr-brightspot.s3.amazonaws.com%2Flegacy%2Fuploads%2F2021%2F1%2F21%2FUHVaccinationJether.jpg)
What are your questions about the coronavirus vaccine?
ideastream's health team is answering as many questions as possible, with help from local experts in a range of fields. You can send us your questions with our online form, through our social media , or call us at 216-916-6476. We'll keep the answers coming on our website and on the air.
Joyce from Cleveland asks: 鈥淎s an African American, I am concerned about the trial testing of the vaccine with people of color. Historically, few African Americans participate in pharmaceutical trials. My level of confidence in taking the vaccine is aligned with this history. How do I find out the trial and testing demographics?"
and , the two companies that have vaccines approved for use in the U.S, did actively recruit diverse participants, said Dr. Amy Ray, an infectious disease specialist from MetroHealth.
African American participants made up about 10 percent for each of the brands, and Black people make up about 13 percent of the U.S. population.
鈥淚 think we should celebrate the fact that these are more reflective,鈥� Dr. Ray said. 鈥淔inally, medical science is reflecting what our population looks like.鈥�
COVID-19 has disproportionately affected the Black community, so it鈥檚 important that the vaccine is tested on people of color so they can be protected against the virus without worrying about vaccine side effects, Ray said
Many people of color are hesitant to sign up for trials, due to a history of racism in research studies.
The scientific community hasn鈥檛 always valued diversity. Historically, clinical trials were typically based on white men of average weight, she said.
Diversity in clinical trials helps doctors and researchers better understand medicine and vaccines, she said. If different races, genders, and weights aren鈥檛 studied, it鈥檚 harder to know how drugs or vaccines would affect a certain population.
In November 2020, the Food and Drug Administration to enhance diversity in clinical trials.
